DENTSPLY SIRONA Inc. (XRAY): Price and Financial Metrics
DENTSPLY SIRONA Inc. (XRAY)
Today's Latest Price: $48.04 USD
Updated Jun 4 4:00pm
Add XRAY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
XRAY Stock Summary
- DENTSPLY SIRONA Inc's market capitalization of $10,480,808,250 is ahead of 85.92% of US-listed equities.
- XRAY's current price/earnings ratio is 125.07, which is higher than 95.58% of US stocks with positive earnings.
- Over the past twelve months, XRAY has reported earnings growth of -119.68%, putting it ahead of just 13.62% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to DENTSPLY SIRONA Inc, a group of peers worth examining would be CINF, Y, ROL, BRO, and WRB.
- XRAY's SEC filings can be seen here. And to visit DENTSPLY SIRONA Inc's official web site, go to www.dentsplysirona.com.
XRAY Stock Price Chart More Charts
XRAY Price/Volume Stats
| Current price | $48.04 | 52-week high | $60.87 |
| Prev. close | $47.84 | 52-week low | $31.58 |
| Day low | $47.09 | Volume | 1,425,228 |
| Day high | $48.47 | Avg. volume | 2,378,571 |
| 50-day MA | $40.89 | Dividend yield | 0.84% |
| 200-day MA | $50.43 | Market Cap | 10.52B |
DENTSPLY SIRONA Inc. (XRAY) Company Bio
DENTSPLY International designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company was founded in 1899 and is based in York, Pennsylvania.
XRAY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $48.04 | $22.88 | -52% |
Below please find a table outlining a discounted cash flow forecast for XRAY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that DENTSPLY SIRONA Inc ranked in the 30th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 52%. The most interesting components of our discounted cash flow analysis for DENTSPLY SIRONA Inc ended up being:
- As a business, XRAY is generating more cash flow than 71.42% of positive cash flow stocks in the Healthcare.
- XRAY's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 36.49% of tickers in our DCF set.
- DENTSPLY SIRONA Inc's effective tax rate, as measured by taxes paid relative to net income, is at 29 -- greater than 89.89% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -53% |
| 1% | -53% |
| 2% | -52% |
| 3% | -52% |
| 4% | -51% |
| 5% | -51% |
Want more companies with a valuation profile/forecast similar to that of DENTSPLY SIRONA Inc? See CAH, IONS, PRAH, BIO, and ESMC.
Loading social stream, please wait...